Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

azenosertibNeutral

AI Analysis

Summary

Zentalis Pharmaceuticals granted 84,000 non-qualified stock options to two newly hired employees as inducement material under Nasdaq Listing Rule 5635(c)(4) and its 2022 Employment Inducement Incentive Award Plan.

Importance:2/10

Sentiment:

0.00

inducement grantsemployee compensationstock optionsNasdaq compliance

Related Companies

$ZNTL

Read the original article

Published by GlobeNewswire Pharma on August 3, 2026 9:00 PM

Read Original